Ameritas Investment Partners’s Karyopharm Therapeutics KPTI Stock Holding History

Ameritas Investment Partners’s Portfolio KPTI Stock Details KPTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-413	Closed	-$9.35K	–	3184
2024 Q1	$9.35K	Hold	413	–	–	﹤0.01%	2827
2023 Q4	$5.36K	Hold	413	–	–	﹤0.01%	2960
2023 Q3	$8.3K	Hold	413	–	–	﹤0.01%	2888
2023 Q2	$11.1K	Hold	413	–	–	﹤0.01%	2873
2023 Q1	$24.1K	Hold	413	–	–	﹤0.01%	2393
2022 Q4	$20.1K	Hold	413	–	–	﹤0.01%	2564
2022 Q3	$33K	Hold	413	–	–	﹤0.01%	2257
2022 Q2	$27K	Hold	413	–	–	﹤0.01%	2387
2022 Q1	$46K	Hold	413	–	–	﹤0.01%	2105
2021 Q4	$40K	Hold	413	–	–	﹤0.01%	2275
2021 Q3	$36K	Hold	413	–	–	﹤0.01%	2360
2021 Q2	$64K	Hold	413	–	–	﹤0.01%	2021
2021 Q1	$65K	Hold	413	–	–	﹤0.01%	1921
2020 Q4	$96K	Hold	413	–	–	﹤0.01%	1605
2020 Q3	$90K	Hold	413	–	–	﹤0.01%	1489
2020 Q2	$117K	Buy	413 +57	+16%	+$16.9K	0.01%	1319
2020 Q1	$103K	Buy	356 +30	+9%	+$8.28K	0.01%	1258
2019 Q4	$94K	Hold	326	–	–	﹤0.01%	1552
2019 Q3	$47K	Buy	326 +58	+22%	+$7.86K	﹤0.01%	1915
2019 Q2	$24K	Hold	268	–	–	﹤0.01%	2343
2019 Q1	$23K	Hold	268	–	–	﹤0.01%	2312
2018 Q4	$38K	Hold	268	–	–	﹤0.01%	1967
2018 Q3	$68K	Hold	268	–	–	﹤0.01%	1802
2018 Q2	$68K	Buy	268 +70	+35%	+$17.3K	﹤0.01%	1804
2018 Q1	$40K	Hold	198	–	–	﹤0.01%	2038
2017 Q4	$28K	Hold	198	–	–	﹤0.01%	2268
2017 Q3	$30K	Hold	198	–	–	﹤0.01%	2191
2017 Q2	$27K	Buy	198 +79	+66%	+$11.7K	﹤0.01%	2294
2017 Q1	$23K	Buy	+119	New	+$19.1K	﹤0.01%	2326

Other funds holding KPTI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Ameritas Investment Partners's KPTI Position: Q2 2024 in Review

Ameritas Investment Partners sold out of Karyopharm Therapeutics (KPTI) in Q2 2024, closing a stake of 413 shares — an estimated $9.35K sold.

Ameritas Investment Partners first reported a position in KPTI in Q1 2017 and held it in 29 quarters. The position peaked at $117K in Q2 2020. 114 funds tracked by Wall St. Rank hold KPTI as of Q2 2024.

Ameritas Investment Partners reported no remaining Karyopharm Therapeutics position as of Q2 2024 after selling out during the quarter.
Ameritas Investment Partners sold 413 Karyopharm Therapeutics shares in Q2 2024, an estimated $9.35K.
Ameritas Investment Partners first reported a position in Karyopharm Therapeutics in Q1 2017 and held it in 29 quarters.
Ameritas Investment Partners's Karyopharm Therapeutics position peaked at $117K in Q2 2020.
114 funds tracked by Wall St. Rank held Karyopharm Therapeutics as of Q2 2024.

Based on Ameritas Investment Partners's 13F filing for Q2 2024, filed 13 Aug 2024.